Acceso abierto

Inhibitory Potential of Murraya Koenigii (L.) and Ficus Carica L. Extracts Against Aldose Reductase (ALR), Advanced Glycation End Products (AGEs) Formation and Sorbitol Accumulation


Cite

1. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med. J. 2012 Jul; 27(4):269-73.10.5001/omj.2012.68 Search in Google Scholar

2. Mehta SR, Kashyap AS, Das S. Diabetes mellitus in India: The modern scourge. Med J. Armed Forces India. 2009 Jan 1; 65(1):50-4.10.1016/S0377-1237(09)80056-7 Search in Google Scholar

3. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2014; 37(1).10.2337/dc14-S08124357215 Search in Google Scholar

4. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 2000 Sep 1; 58:S3-12.10.1046/j.1523-1755.2000.07702.x10997684 Search in Google Scholar

5. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Clin J Am Soc Nephrol. 2005 Sep 1; 16(9):2690-701.10.1681/ASN.200412108415987752 Search in Google Scholar

6. Meier M, Menne J, Park JK, Haller H. Nailing down PKC isoform specificity in diabetic nephropathy—two’s company, three’s a crowd. Nephrol Dial Transplant. 2007; 22:2421-2425.10.1093/ndt/gfm32017724056 Search in Google Scholar

7. Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, et al. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes. 2008; 57:1002–17.10.2337/db07-033918039814 Search in Google Scholar

8. Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocininduced mouse model of diabetes. Diabetologia. 2008; 51:2126-33.10.1007/s00125-008-1136-3304443718802679 Search in Google Scholar

9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–20.10.1038/414813a11742414 Search in Google Scholar

10. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 1999 Mar 19; 84(5):489-97.10.1161/01.RES.84.5.489 Search in Google Scholar

11. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998 Mar 1; 50(1):21-34. Search in Google Scholar

12. Reddy GB, Muthenna P, Akileshwari C, Saraswat M, Petrash JM. Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Curr. Sci. 2011 Nov; 10:1191-7. Search in Google Scholar

13. Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol. Res. Commun. 2014 Feb 1; 80:21-35.10.1016/j.phrs.2013.12.00524373831 Search in Google Scholar

14. Jung HA, Jung YJ, Yoon NY, Jeong DM, Bae HJ, Kim DW, et al. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 2008 Dec 1; 46(12):3818-26.10.1016/j.fct.2008.10.00418952135 Search in Google Scholar

15. Vijayanand S. Evaluation of Antidiabetic activity of Murraya koenigii on Alloxan Induced Diabetic rats. Int. J. Pharm. Sci. Res. 2015; 6(12):1401-05. Search in Google Scholar

16. Saini SC, Reddy GBS. Murraya koenigii. J Pharm Biol Sci. 2013; 7(6):15-18. Search in Google Scholar

17. Vandana J. Murraya Koenigii: An Updated Review. Int. j. Ayurvedic herb. med. 2012; 2(4): 607-627. Search in Google Scholar

18. Saini CS, Reddy GBS. A Review on Curry Leaves (Murraya koenigii): Versatile Multi-Potential Medicinal Plant. American Journal of Phytomedicine and Clinical Therapeutics, 2015; 3(4); 363-368. Search in Google Scholar

19. Stephen IS, Christudas S, Antony S, Duraipandiyan V, Naif AAD, Ignacimuthu S. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats. Pharm. Biol. 2017 Jan 1; 55(1):1074-10.1080/13880209.2017.1279671613066128193094 Search in Google Scholar

20. Tchombe LN, Louajri A. Therapeutic effects of Ficus carica leaves: A brief review. ARPN J. Sci. Technol. 2015; 5:37-41. Search in Google Scholar

21. Badgujar SB, Patel VV, Bandivdekar AH, Mahajan RT. Traditional uses, phytochemistry and pharmacology of Ficus carica: A review. Pharm. Biol. 2014 Nov 1; 52(11):1487-503.10.3109/13880209.2014.89251525017517 Search in Google Scholar

22. Krishna MG, Pallavi E, Ravi KB, Ramesh M, Venkatesh S. Hepatoprotective activity of Ficus carica Linn. leaf extract against carbon tetrachloride-induced hepatotoxicity in rats. DARU. 2007; 15(3):162-166. Search in Google Scholar

23. Mawa S, Husain K, Jantan I. Ficus carica L. (Moraceae): Phytochemistry, Traditional Uses and Biological Activities. Evid Based Complement Alternat Med. 2013; 2013:974256.10.1155/2013/974256378940224159359 Search in Google Scholar

24. Kawanishi K, Ueda H, Moriyasu M. Aldose reductase inhibitors from the nature. Curr. Med. 2003 Aug 1; 10(15):1353-74.10.2174/092986703345730412871134 Search in Google Scholar

25. Manzanaro S, Salvá J, de la Fuente JÁ. Phenolic marine natural products as aldose reductase inhibitors. J. Nat. Prod. 2006 Oct 27; 69(10):1485-7.10.1021/np050369817067167 Search in Google Scholar

26. de la Fuente JÁ, Manzanaro S, Martín MJ, de Quesada TG, Reymundo I, Luengo SM, et al. Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product. J. Med. Chem. 2003 Nov 20; 46(24):5208-21.10.1021/jm030957n14613323 Search in Google Scholar

27. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac. J. Clin. Nutr. 2008 Dec 1; 17(4) ):558-65. Search in Google Scholar

28. Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 2003 Dec 1; 11(24):5317-23.10.1016/j.bmc.2003.09.04514642575 Search in Google Scholar

29. Haraguchi H, Ohmi I, Fukuda A, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci Biotechnol Biochem. 1997 Apr 23; 61(4):651-4.10.1271/bbb.61.6519145524 Search in Google Scholar

30. Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents based approach. J. Ethnopharmacol. 2013 Oct 28; 150(1): 51-70.10.1016/j.jep.2013.08.051 Search in Google Scholar

31. Kajal A, Singh R. Modulation of advanced glycation end products, sorbitol, and aldose reductase by hydroalcohol extract of Lagenaria siceraria mol standl in diabetic complications: an in vitro approach. J. Diet. Suppl. 2018 Jul 4; 15(4):482-98.10.1080/19390211.2017.1356419 Search in Google Scholar

32. Kishore L, Kaur N, Kajal A, Singh R. Extraction, characterization and evaluation of Eruca sativa against streptozotocin- induced diabetic nephropathy in rat. Bangladesh J. Pharmacol. 2017 Jun 30; 12(2):216-27.10.3329/bjp.v12i2.32065 Search in Google Scholar

33. da Silva Morrone M, de Assis AM, da Rocha RF, Gasparotto J, Gazola AC, Costa GM, et al. Passiflora manicata (Juss.) aqueous leaf extract protects against reactive oxygen species and protein glycation in vitro and ex vivo models. Food Chem. Toxicol. 2013 Oct 1; 60:45-51.10.1016/j.fct.2013.07.028 Search in Google Scholar

34. Kishore L, Kaur N, Singh R. Renoprotective effect of Bacopa monnieri via inhibition of advanced glycation end products and oxidative stress in STZ-nicotinamideinduced diabetic nephropathy. Ren. Fail. 2016 Oct 20;3 8(9):1528-44.10.1080/0886022X.2016.1227920 Search in Google Scholar

35. Shimizu M, Ito T, Terashima S, Hayashi T, et. al. Inhibition of lens aldose reductase by flavonoids. Phytochemistry. 1984; 23(9):1885-8.10.1016/S0031-9422(00)84935-3 Search in Google Scholar

36. Ghamali M, Chtita S, Hmamouchi R, Adad A, Bouachrine M, Lakhlifi T. The inhibitory activity of aldose reductase of flavonoid compounds: Combining DFT and QSAR calculations. J. Tiabah Univ. Sci. 2016; 10(4):534-42. Search in Google Scholar

37. Patil KK, Gacche RN. Inhibition of glycation and aldose reductase activity using dietary flavonoids: A lens organ culture studies. Int. J. Biol. Macromol. 2017; 98:730-8. Search in Google Scholar

38. Aju BY, Rajalakshmi R, Mini S. Evaluation of antioxidant activity of Murraya koenigii (L.) Spreng using different in vitro methods. J. Pharmacogn. Phytochem. 2017; 6(4): 939-942. Search in Google Scholar

39. Trifunschi SI, Ardelean DG. Flavonoid extraction from Ficus carica leaves using different techniques and solvents. Zbornik Matice srpske za prirodne nauke. 2013(125):81-6.10.2298/ZMSPN1325081T Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other